News

In this month's Legal Eagle column, David J. Goldberg, MD, JD, discusses a case involving a dermatologist performing plastic surgery.

As we continue to face the COVID-19 pandemic and its long-term consequences, it is more important than ever for providers to build trust with patients.

This week's edition of the Mainstream Patient features stories about facial exfoliators, skin-picking disorders, hydra-facials, and more.

Move comes after FDA give emergency use authorization for bivalent vaccines.

Sarah Higgins, DNP, APRN, WHNP-BC, discusses the best career advice she ever got, what she believes is the biggest myth in the aesthetic industry, and what changes she would like to see take place in the field of aesthetic dermatology.

ICYMI, this week we had stories about non-prescription acne treatments, clinical study results, pediatric atopic dermatitis, and the EADV 2022 Congress.

Revelle Aesthetics’ cellulite reduction device helps address frustrating aesthetic concerns.

AnaptysBio will refocus R&D efforts on its immune cell modulator pipeline.

Topline data expected in the first half of 2023.

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of August.

Abstracts will include updates on treatment for psoriatic arthritis, psoriasis, atopic dermatitis, and more.

Positioning your portfolio for price stability and growth.

New research by the National Eczema Association has revealed the importance of patient input into treatment decisions.

This week's edition of the Mainstream Patient features stories about tattoo aftercare, expert-reviewed wrinkle creams, trending Latinx beauty brands, and more.

ICYMI, this week we had stories about adherence issues in acne treatment, shin guard dermatitis, atopic dermatitis in skin of color patients, clinical trial news from Arcutis Biotherapeutics, and more.

Domestic production to begin at Michigan-based pharmaceutical maker.

Emergency Use Authorization provides a 2-dose primary series given 3 weeks apart.

This week's edition of the Mainstream Patient features stories about psoriasis in skin of color, the best facial cleansing brushes, a new acne-focused skin care line, Joe Jonas' experience with injectables, and more.

ICYMI, this week we had stories about psoriasis and tattoos, shin guard dermatitis, rosacea symptoms, a new treatment option for severe burns, and more.

Physicians groups, analysts, have praised insurance premium subsidies, Medicare drug cost caps.

MediWound’s new burn care therapy alleviates risks associated with surgical debridement.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses the 5 biggest cleansing mistakes.

Patients are either skipping care completely, cutting costs elsewhere, or borrowing money to pay for health care

This week's edition of the Mainstream Patient features stories about adult acne, Native American beauty products, a non-irritating retinol serum, beauty brands that support abortion rights, and more.

ICYMI, this week we had stories about product recalls, FDA warning letters, pediatric atopic dermatitis, acne treatment, and more.

VYNE Therapeutics Inc. announced the results of study VY2021-01.

Amazon, Ariella Naturals, and Justified Laboratories received warning letters from the FDA.

Edgewell Personal Care Company issued a voluntary national recall of 3 collections of Banana Boat Hair & Scalp Sunscreen due to the presence of benzene.

In this month's Legal Eagle, David J. Goldberg, MD, JD, discusses a legal situation involving an oculoplastic surgeon and a covering physician.